Evaluation of next generation sequencing platforms for population targeted sequencing studies.

Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA. · 2009

Read Evaluation of next generation sequencing platforms for population targeted sequencing studies. by Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2691003.txt.

Description

Harismendy and colleagues compared in 2009 the three new high-speed DNA sequencing platforms then challenging the classic Sanger method. The newcomers, from Roche, Illumina, and ABI, produced thousands of times more sequence at far lower cost. The team tested them on the same job: targeted sequencing of chosen regions in four samples.

Each platform read the same 260,000-letter stretch using its maker's own preparation and software. All three worked, but their coverage was uneven in a telling way. Stretches with certain local sequence features were read deeply, while neighbors went thin, and the pattern differed by platform. Systematic bias, not random chance, explained the gaps. For studies sequencing many people's candidate regions, the authors warn, platform choice shapes which spots are trustworthy, and results across platforms are not simply interchangeable.

Catalog record

CREATORHarismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2691003

Browse the full library · About the Tower of Babel